Edegem

• A study to learn if UCB3101 is safe and how it moves through the body of healthy participants Ended
  2023-504586-24-00 1 2024-07-31 Healthy Participants
• A study to test how well healthy people tolerate spesolimab when given in 2 different ways. Ended
  2023-510448-20-00 3 2024-07-30 Healthy volunteer trial
• An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian … Ended
  2023-508149-42-00 3 2024-07-16 Infertility in women undergoing assisted reproductive technologies (AR
• A study to learn how safe KER-0193 is, the activity of KER-0193 in the body over a period of time, and the effect of KER-0193 to the body in … Ended
  2024-511468-94-00 1 2024-07-10 Fragile X syndrome
• Comparison of the study drug CHF 1535 formulated with two different propellants to learn about drug levels in blood and safety after inhalat … Ended
  2023-510171-59-00 3 2024-06-17 Asthma and chronic obstructive pulmonary disease (COPD).
• A Phase I, randomized, double-blind, multi-centre, placebo-controlled, dose-escalation study to evaluate the safety, reactogenicity and immu … Ended
  2024-511194-29-00 1 2024-06-16 Yellow fever
• A study on the immune response and safety of a vaccine against respiratory syncytial virus (RSV) when given alone and together with a vaccin … Ended
  2023-510196-59-00 5 2024-06-15 Respiratory Syncytial Virus Infections
• A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy. Ended
  2023-504892-25-00 5 2024-06-14 Narcolepsy
• An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation Ended
  2023-507630-25-00 3 2024-06-14 Infertility in women undergoing assisted reproductive technologies (AR
• A study evaluating the safety and efficacy of GLPG5101 (19CP02) in subjects with non-Hodgkin lymphoma Ended
  2022-502661-23-00 7 2024-06-11 Relapsed/refractory B-cell non-Hodgkin lymphoma
• MK-7091 Formulations Study in Healthy Adult Participants Ended
  2023-510402-40-00 3 2024-06-07 Hypercholesterolemia
• A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherap … Ended
  2022-502653-34-01 11 2024-05-30 Atopic dermatitis and moderate-to severe atopic hand eczema
• A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants Ended
  2024-511405-27-00 3 2024-05-08 Amyotrophic lateral sclerosis and Alzheimer’s disease
• A study in healthy men and women to test whether BI 1569912 influences the amount of repaglinide, midazolam and bupropion in the blood Ended
  2023-510461-10-00 3 2024-05-07 Healthy volunteer trial
• Safety and tolerability of single and multiple ascending doses of lunsekimig (SAR443765) in healthy participants Ended
  2023-509316-28-00 3 2024-05-06 Asthma
• A Study to Investigate the Pharmacokinetics (PK) and Safety of Risdiplam in Infants with Spinal Muscular Atrophy Ended
  2023-505602-42-00 4 2024-04-30 Spinal Muscular Atrophy (SMA)
• A study to test how well multiple doses of BI 765423 are tolerated by healthy men Ended
  2023-506722-36-00 3 2024-04-30 Healthy volunteer trial
• Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) Ended
  2022-502899-23-00 5 2024-04-23 Hepatic Encephalopathy (OHE)
• A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants with Cirrhosis-ZEAL-UNLOCK Ended
  2023-506893-11-00 4 2024-04-19 Cirrhosis of the liver is a condition in which the liver is scarred an
• Regorafenib-pembrolizumab vs. TACE/TARE in intermediate-stage HCC beyond up-to-7. Ended
  2022-501969-42-00 5 2024-03-28 Intermediate-stage hepatocellular carcinoma with beyond up-to-7 criter
• A study in healthy people to test how well different doses of BI 3000202 are tolerated and how they affect the way the body handles midazola … Ended
  2023-509293-29-00 3 2024-03-28 Healthy volunteer trial
• TACTIVE-U: An Umbrella Study to Investigate the Safety and Antitumor Activity of vepdegestrant (ARV-471) in Combination With Other Medicines … Ended
  2023-507125-41-00 9 2024-03-25 Advanced or Metastatic Breast Cancer
• A study to learn about how elinzanetant works and how safe it is in women having sleep disturbances associated with menopause Ended
  2023-504955-28-01 4 2024-03-14 Sleep disturbances associated with menopause
• A study to learn how effective and safe the drug “mirabegron” is and how long it stays in the body of children aged 6 months to less than 3 … Ended
  2023-507903-74-00 5 2024-02-28 Neurogenic detrusor overactivity (NDO)

Showing 457–480 of 590 trials